The pharmacist’s role in aiding patients seeking relief includes a careful evaluation of pain severity, medical history, and exclusions for self-treatment.
The November 2023 ACC/AHA/ACCP/HRS release suggests early, aggressive rhythm control and provides parameters for pausing or stopping therapies, among other recommendations.